TREZIX Drug Patent Profile
✉ Email this page to a colleague
When do Trezix patents expire, and when can generic versions of Trezix launch?
Trezix is a drug marketed by Key Therap and is included in one NDA.
The generic ingredient in TREZIX is acetaminophen; caffeine; dihydrocodeine bitartrate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TREZIX?
- What are the global sales for TREZIX?
- What is Average Wholesale Price for TREZIX?
Summary for TREZIX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Patent Applications: | 12 |
| DailyMed Link: | TREZIX at DailyMed |
Pharmacology for TREZIX
| Drug Class | Central Nervous System Stimulant Methylxanthine Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
| Physiological Effect | Central Nervous System Stimulation |
US Patents and Regulatory Information for TREZIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key Therap | TREZIX | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 204785-001 | Nov 26, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
